BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bauml MA, Underwood DA. Left ventricular hypertrophy: An overlooked cardiovascular risk factor. Cleve Clin J Med. 2010;77:381-387. [PMID: 20516249 DOI: 10.3949/ccjm.77a.09158] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Hicken MT, Adar SD, Hajat A, Kershaw KN, Do DP, Barr RG, Kaufman JD, Diez Roux AV. Air Pollution, Cardiovascular Outcomes, and Social Disadvantage: The Multi-ethnic Study of Atherosclerosis. Epidemiology 2016;27:42-50. [PMID: 26618771 DOI: 10.1097/EDE.0000000000000367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
2 Braunstein ED, Croft LB, Halperin JL, Liao SL. Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy. World J Cardiol 2019;11:94-102. [PMID: 31040932 DOI: 10.4330/wjc.v11.i3.94] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ding W, Dong M, Deng J, Yan D, Liu Y, Xu T, Liu J. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca 2+ handling and calcineurin-NFAT signaling pathway. American Journal of Physiology-Heart and Circulatory Physiology 2014;307:H792-802. [DOI: 10.1152/ajpheart.00017.2014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
4 Sankar V, Nair RR, Harikrishnan VS, Fernandez AC, Kumar CS, Madhavachandran V. Cardoguard, an Ayurvedic antihypertensive formulation, prevents cardiac remodeling in spontaneously hypertensive rats by inhibition of ERK and PKCε signaling pathways. Can J Physiol Pharmacol 2012;90:627-35. [PMID: 22550975 DOI: 10.1139/y2012-047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 di Giuseppe R, Kühn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study. Eur J Epidemiol 2015;30:131-41. [PMID: 25527370 DOI: 10.1007/s10654-014-9982-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
6 Liu YH, Lu M, Xie ZZ, Hua F, Xie L, Gao JH, Koh YH, Bian JS. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. Antioxid Redox Signal 2014;20:759-69. [PMID: 23581627 DOI: 10.1089/ars.2012.4888] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
7 Rodrigo C, Weerasinghe S, Jeevagan V, Rajapakse S, Constantine G. Addressing the relationship between cardiac hypertrophy and ischaemic stroke: an observational study. Int Arch Med 2012;5:32. [PMID: 23241476 DOI: 10.1186/1755-7682-5-32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Rizos CV. Manidipine: A different dihydropyridine. WJH 2011;1:3. [DOI: 10.5494/wjh.v1.i1.3] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Li L, Xu J, He L, Peng L, Zhong Q, Chen L, Jiang Z. The role of autophagy in cardiac hypertrophy. Acta Biochim Biophys Sin (Shanghai) 2016;48:491-500. [PMID: 27084518 DOI: 10.1093/abbs/gmw025] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
10 Dykun I, Geisel MH, Kälsch H, Lehmann N, Bauer M, Moebus S, Jöckel K, Möhlenkamp S, Erbel R, Mahabadi AA. Association of computed tomography-derived left ventricular size with major cardiovascular events in the general population: The Heinz Nixdorf recall study. Atherosclerosis 2015;240:46-52. [DOI: 10.1016/j.atherosclerosis.2015.02.050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Nyaga UF, Boombhi J, Menanga A, Mokube M, Ndomo Mevoula CS, Kingue S, Noubiap JJ. Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population. J Clin Hypertens (Greenwich) 2021;23:1186-93. [PMID: 33783138 DOI: 10.1111/jch.14243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jobe M, Kane A, Jones JC, Pessinaba S, Nkum BC, Abdou Ba S, Nyan OA. Electrocardiographic Left Ventricular Hypertrophy Among Gambian Diabetes Mellitus Patients. Ghana Med J 2015;49:19-24. [PMID: 26339080 DOI: 10.4314/gmj.v49i1.4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Njoku PO, Ejim EC, Anisiuba BC, Ike SO, Onwubere BJ. Electrocardiographic findings in a cross-sectional study of human immunodeficiency virus (HIV) patients in Enugu, south-east Nigeria. Cardiovasc J Afr 2016;27:252-7. [PMID: 27841913 DOI: 10.5830/CVJA-2016-007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sparapani R, Dabbouseh NM, Gutterman D, Zhang J, Chen H, Bluemke DA, Lima JAC, Burke GL, Soliman EZ. Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA. J Am Heart Assoc 2019;8:e009959. [PMID: 30827132 DOI: 10.1161/JAHA.118.009959] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
15 Wang E, Chong K, Yu M, Akhoundsadegh N, Granville DJ, Shapiro J, McElwee KJ. Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice. PLoS One 2013;8:e62935. [PMID: 23658656 DOI: 10.1371/journal.pone.0062935] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
16 Krittanawong C, Tunhasiriwet A, Wang Z, Zhang H, Prokop LJ, Chirapongsathorn S, Sun T, Kitai T, Tang WW. Meta-Analysis Comparing Frequency of Overweight Versus Normal Weight in Patients With New-Onset Heart Failure. The American Journal of Cardiology 2018;121:836-43. [DOI: 10.1016/j.amjcard.2017.12.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rossoni LV, Oliveira RA, Caffaro RR, Miana M, Sanz-Rosa D, Koike MK, Do Amaral SL, Michelini LC, Lahera V, Cachofeiro V. Cardiac benefits of exercise training in aging spontaneously hypertensive rats. J Hypertens 2011;29:2349-58. [PMID: 22045123 DOI: 10.1097/HJH.0b013e32834d2532] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
18 Okwuosa TM, Soliman EZ, Lopez F, Williams KA, Alonso A, Ferdinand KC. Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study. Am Heart J 2015;169:155-61.e5. [PMID: 25497261 DOI: 10.1016/j.ahj.2014.09.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
19 Nagoor Meeran MF, Jagadeesh GS, Selvaraj P. Thymol attenuates altered lipid metabolism in β-adrenergic agonist induced myocardial infarcted rats by inhibiting tachycardia, altered electrocardiogram, apoptosis and cardiac hypertrophy. Journal of Functional Foods 2015;14:51-62. [DOI: 10.1016/j.jff.2015.01.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
20 Liu W, Deng J, Ding W, Wang G, Shen Y, Zheng J, Zhang X, Luo Y, Lv C, Wang Y, Chen L, Yan D, Boudreau RL, Song LS, Liu J. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Circ Heart Fail 2017;10:e003960. [PMID: 28611128 DOI: 10.1161/CIRCHEARTFAILURE.117.003960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
21 Xue R, Zeng J, Chen Y, Chen C, Tan W, Zhao J, Dong B, Sun Y, Dong Y, Liu C. Sestrin 1 ameliorates cardiac hypertrophy via autophagy activation. J Cell Mol Med 2017;21:1193-205. [PMID: 28181410 DOI: 10.1111/jcmm.13052] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 7.8] [Reference Citation Analysis]
22 Noubiap JJ, Agbaedeng TA, Nyaga UF, Nkoke C, Jingi AM. A meta-analytic evaluation of the diagnostic accuracy of the electrocardiographic Peguero-Lo Presti criterion for left ventricular hypertrophy. J Clin Hypertens (Greenwich) 2020;22:1145-53. [PMID: 32608577 DOI: 10.1111/jch.13923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ebong IA, Goff DC Jr, Rodriguez CJ, Chen H, Bertoni AG. Mechanisms of heart failure in obesity. Obes Res Clin Pract 2014;8:e540-8. [PMID: 25434909 DOI: 10.1016/j.orcp.2013.12.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 42] [Article Influence: 8.6] [Reference Citation Analysis]
24 Xue R, Jiang J, Dong B, Tan W, Sun Y, Zhao J, Chen Y, Dong Y, Liu C. DJ-1 activates autophagy in the repression of cardiac hypertrophy. Arch Biochem Biophys 2017;633:124-32. [PMID: 28941803 DOI: 10.1016/j.abb.2017.09.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
25 Goh SS, Sia C, Ngiam NJ, Tan BY, Lee PS, Tay EL, Kong WK, Yeo TC, Poh K. Effect of Renin-Angiotensin Blockers on Left Ventricular Remodeling in Severe Aortic Stenosis. The American Journal of Cardiology 2017;119:1839-45. [DOI: 10.1016/j.amjcard.2017.02.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
26 Govindaraju DR, Pencina KM, Raj DS, Massaro JM, Carnes BA, D'Agostino RB. A systems analysis of age-related changes in some cardiac aging traits. Biogerontology 2014;15:139-52. [PMID: 24337960 DOI: 10.1007/s10522-013-9486-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
27 Schneider RH, Myers HF, Marwaha K, Rainforth MA, Salerno JW, Nidich SI, Gaylord-King C, Alexander CN, Norris KC. Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans. Ethn Dis 2019;29:577-86. [PMID: 31641325 DOI: 10.18865/ed.29.4.577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Derosa G, Maffioli P. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure. Expert Rev Cardiovasc Ther 2013;11:719-28. [PMID: 23750681 DOI: 10.1586/erc.13.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
29 Liu C, Xue R, Wu D, Wu L, Chen C, Tan W, Chen Y, Dong Y. REDD1 attenuates cardiac hypertrophy via enhancing autophagy. Biochem Biophys Res Commun 2014;454:215-20. [PMID: 25450383 DOI: 10.1016/j.bbrc.2014.10.079] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
30 Lv T, Yuan Y, Yang J, Wang G, Kong L, Li H, Li X, Sun Y, Li X, Zhang Z, Cheng X, Wu L, Tan X, Han B, Li H, Zhang Z, Wang J, Wu Y, Wang Y, Guo J, Zhang P. The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population. Ann Noninvasive Electrocardiol 2021;26:e12880. [PMID: 34310813 DOI: 10.1111/anec.12880] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Thambiraj G, Gandhi U, Mangalanathan U, Jose VJM, Anand M. Investigation on the effect of Womersley number, ECG and PPG features for cuff less blood pressure estimation using machine learning. Biomedical Signal Processing and Control 2020;60:101942. [DOI: 10.1016/j.bspc.2020.101942] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
32 Ciulla MM, Acquistapace G, Perrucci GL, Nicolini P, Toffetti L, Braidotti P, Ferrero S, Zucca I, Aquino D, Busca G, Magrini F. Immunohistochemical expression of oncological proliferation markers in the hearts of rats during normal pregnancy. Biomarkers in Medicine 2013;7:119-29. [DOI: 10.2217/bmm.12.94] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]